M. Nosadini Et Al. , "Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis A Meta-analysis," JAMA NEUROLOGY , vol.78, no.11, pp.1333-1344, 2021
Nosadini, M. Et Al. 2021. Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis A Meta-analysis. JAMA NEUROLOGY , vol.78, no.11 , 1333-1344.
Nosadini, M., Eyre, M., Molteni, E., Thomas, T., Irani, S. R., Dalmau, J., ... Dale, R. C.(2021). Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis A Meta-analysis. JAMA NEUROLOGY , vol.78, no.11, 1333-1344.
Nosadini, Margherita Et Al. "Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis A Meta-analysis," JAMA NEUROLOGY , vol.78, no.11, 1333-1344, 2021
Nosadini, Margherita Et Al. "Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis A Meta-analysis." JAMA NEUROLOGY , vol.78, no.11, pp.1333-1344, 2021
Nosadini, M. Et Al. (2021) . "Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis A Meta-analysis." JAMA NEUROLOGY , vol.78, no.11, pp.1333-1344.
@article{article, author={Margherita Nosadini Et Al. }, title={Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis A Meta-analysis}, journal={JAMA NEUROLOGY}, year=2021, pages={1333-1344} }